Emanuele Messina

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Re: De Luca et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2026;89:246-57.

Re: De Luca et al. Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA). Eur Urol 2026;89:246-57.

Journal: European urology

Published: May 29, 2026

Reply to the Letter to the Editor: Artificial intelligence for prostate MRI screening-methodological considerations regarding reference standards and reader design.

Reply to the Letter to the Editor: Artificial intelligence for prostate MRI screening-methodological considerations regarding reference standards and reader design.

Journal: European radiology

Published: April 13, 2026

Reply to Andrew R. A. Godtman et al.'s Letter to the Editor re: The PROSA Trial: Some Prosaic Comments. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.036.

Reply to Andrew R. A. Godtman et al.'s Letter to the Editor re: The PROSA Trial: Some Prosaic Comments. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.036.

Journal: European urology

Published: April 08, 2026

Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.

Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.

Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine

Published: March 26, 2026

VI-RADS Score Performance in the Post-TURBT Setting: Exploring the Need for Modification.

VI-RADS Score Performance in the Post-TURBT Setting: Exploring the Need for Modification.

Journal: European urology oncology

Published: January 23, 2026

Digital twin technologies in prostate cancer as a frontier for precision medicine.

Digital twin technologies in prostate cancer as a frontier for precision medicine.

Journal: European radiology experimental

Published: December 14, 2025

Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan.

Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan.

Journal: European urology focus

Published: November 29, 2025

Contrast-free MRI-first screening in young asymptomatic men: Prostate characteristics and cancer detection rates.

Contrast-free MRI-first screening in young asymptomatic men: Prostate characteristics and cancer detection rates.

Journal: Prostate cancer and prostatic diseases

Published: November 28, 2025

Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.

Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.

Journal: European radiology

Published: October 30, 2025

Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA).

Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA).

Journal: European urology

Published: August 06, 2025

Artificial intelligence-assisted reading of non-contrast prostate MRI: application and concordance with expert interpretation in a screening population within the PROSA trial.

Artificial intelligence-assisted reading of non-contrast prostate MRI: application and concordance with expert interpretation in a screening population within the PROSA trial.

Journal: European radiology

Published: July 25, 2025

AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer.

AI-assessed sarcopenia as an independent predictor of neoadjuvant chemotherapy outcomes in muscle-invasive bladder cancer.

Journal: La Radiologia medica

Published: June 03, 2025

Showing 1-12 of 48

Last Updated: 09/26/2026